Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleSpecial Contributions

PET as a Tool in the Clinical Evaluation of Pituitary Adenomas

Mats Bergström, Carin Muhr, P.O. Lundberg and Bengt Långström
Journal of Nuclear Medicine April 1991, 32 (4) 610-615;
Mats Bergström
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carin Muhr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.O. Lundberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bengt Långström
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 32, Issue 4
April 1, 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PET as a Tool in the Clinical Evaluation of Pituitary Adenomas
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PET as a Tool in the Clinical Evaluation of Pituitary Adenomas
Mats Bergström, Carin Muhr, P.O. Lundberg, Bengt Långström
Journal of Nuclear Medicine Apr 1991, 32 (4) 610-615;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PET as a Tool in the Clinical Evaluation of Pituitary Adenomas
Mats Bergström, Carin Muhr, P.O. Lundberg, Bengt Långström
Journal of Nuclear Medicine Apr 1991, 32 (4) 610-615;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Using Molecular Imaging to Enhance Decision Making in the Management of Pituitary Adenomas
  • PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study
  • Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11C-methionine PET co-registered with MRI
  • A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome
  • Small-Animal PET with a {sigma}-Ligand, 11C-SA4503, Detects Spontaneous Pituitary Tumors in Aged Rats
  • Diagnostic imaging of dopamine receptors in pituitary adenomas
  • Use of Stereotactic PET Images in Dosimetry Planning of Radiosurgery for Brain Tumors: Clinical Experience and Proposed Classification
  • [11C]Methionine Positron Emission Tomography and Survival in Patients with Bone and Soft Tissue Sarcomas Treated by Carbon Ion Radiotherapy
  • Google Scholar

More in this TOC Section

  • The Use of Published Clinical Study Reports to Support U.S. Food and Drug Administration Approval of Imaging Agents
  • Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites
  • American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET
Show more Special Contributions

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire